Disease areas:
  • heart and blood vessels
Last updated:
Author(s):
Audunn S. Snaebjarnarson, Anna Helgadottir, Gudny A. Arnadottir, Erna V. Ivarsdottir, Gudmar Thorleifsson, Egil Ferkingstad, Gudmundur Einarsson, Gardar Sveinbjornsson, Thorgeir E. Thorgeirsson, Magnus O. Ulfarsson, Bjarni V. Halldorsson, Isleifur Olafsson, Christian Erikstrup, Ole B. Pedersen, Mette Nyegaard, Mie T. Bruun, Henrik Ullum, Søren Brunak, Kasper Karmark Iversen, Alex Hoerby Christensen, Morten S. Olesen, Jonas Ghouse, Karina Banasik, DBDS Genomic Consortium, Kirk U. Knowlton, David O. Arnar, Gudmundur Thorgeirsson, Lincoln Nadauld, Sisse Rye Ostrowski, Henning Bundgaard, Hilma Holm, Patrick Sulem, Kari Stefansson, Daniel F. Gudbjartsson
Publish date:
1 September 2023
Journal:
Cell
PubMed ID:
37714134

Abstract

Many sequence variants have additive effects on blood lipid levels and, through that, on the risk of coronary artery disease (CAD). We show that variants also have non-additive effects and interact to affect lipid levels as well as affecting variance and correlations. Variance and correlation effects are often signatures of epistasis or gene-environmental interactions. These complex effects can translate into CAD risk. For example, Trp154Ter in FUT2 protects against CAD among subjects with the A1 blood group, whereas it associates with greater risk of CAD in others. His48Arg in ADH1B interacts with alcohol consumption to affect lipid levels and CAD. The effect of variants in TM6SF2 on blood lipids is greatest among those who never eat oily fish but absent from those who often do. This work demonstrates that variants that affect variance of quantitative traits can allow for the discovery of epistasis and interactions of variants with the environment.

Related projects

The last two decades have seen major progress in human genetics research in particular due to technological advancements and the success of the genome-wide association…

Institution:
deCODE Genetics, Iceland

All projects